33 related articles for article (PubMed ID: 11848470)
21. Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts.
Teicher BA; Menon K; Alvarez E; Liu P; Shih C; Faul MM
In Vivo; 2001; 15(3):185-93. PubMed ID: 11491013
[TBL] [Abstract][Full Text] [Related]
22. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts.
Teicher BA; Menon K; Alvarez E; Shih C; Faul MM
Invest New Drugs; 2002 Aug; 20(3):241-51. PubMed ID: 12201487
[TBL] [Abstract][Full Text] [Related]
23. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in murine lewis lung carcinoma and human Calu-6 non-small-cell lung carcinoma xenografts.
Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul MM
Cancer Chemother Pharmacol; 2001 Dec; 48(6):473-80. PubMed ID: 11800028
[TBL] [Abstract][Full Text] [Related]
24. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.
Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul M
Clin Cancer Res; 2001 Mar; 7(3):634-40. PubMed ID: 11297259
[TBL] [Abstract][Full Text] [Related]
25. Antiangiogenic effects of a protein kinase Cbeta-selective small molecule.
Teicher BA; Alvarez E; Menon K; Esterman MA; Considine E; Shih C; Faul MM
Cancer Chemother Pharmacol; 2002 Jan; 49(1):69-77. PubMed ID: 11855754
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.
Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul MM
Anticancer Res; 2001; 21(5):3175-84. PubMed ID: 11848470
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy for renal cell cancer: what are possible options?
Santos N; Wenger JB; Havre P; Liu Y; Dagan R; Imanirad I; Ivey AM; Zlotecki RA; Algood CB; Gilbert SM; Allegra CJ; Okunieff P; Vieweg J; Dang NH; Luesch H; Dang LH
Oncology; 2011; 81(3-4):220-9. PubMed ID: 22085914
[TBL] [Abstract][Full Text] [Related]
28. Targeting angiogenesis in metastatic renal cell carcinoma.
Canino C; Perrone L; Bosco E; Saltalamacchia G; Mosca A; Rizzo M; Porta C
Expert Rev Anticancer Ther; 2019 Mar; 19(3):245-257. PubMed ID: 30678509
[TBL] [Abstract][Full Text] [Related]
29. Basis for effective combination cancer chemotherapy with antimetabolites.
Peters GJ; van der Wilt CL; van Moorsel CJ; Kroep JR; Bergman AM; Ackland SP
Pharmacol Ther; 2000; 87(2-3):227-53. PubMed ID: 11008002
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]